Study Stopped
The project was not funded.
Brain-imaging and Adolescent Neuroscience Consortium
BANC
1 other identifier
observational
N/A
1 country
4
Brief Summary
This is a multi-site study of adolescents 12-21 years-of-age to evaluate the long and shorter-term effect of adolescent alcohol use on the developing brain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2012
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2012
CompletedFirst Posted
Study publicly available on registry
January 19, 2012
CompletedStudy Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedJanuary 3, 2013
January 1, 2013
4.5 years
January 13, 2012
January 2, 2013
Conditions
Keywords
Study Arms (3)
Alcohol-naive adolescents
A general population longitudinal cohort of alcohol-naïve (or h/o minimal recent-onset drinking) adolescents in three specific age-groups: early (12-14 y/o), middle (15-17 y/o), and late (18-21 y/o).
Treatment sample
A sample of adolescents who have a \>1 year history of heavy drinking but have agreed to stop drinking as part of their treatment plan
High risk sample
High-risk adolescents who have a family history of alcohol-use disorder and other risk factors (symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD), Conduct Disorder, or Mood Disorder)
Eligibility Criteria
Male and female adolescents 12-21 years-of-age presenting for care at one of the participating medical clinics
You may qualify if:
- able to read and understand English
- available for follow-up
- parental consent/adolescent assent for those 12-17 years
- consent for those 18-21 years
You may not qualify if:
- Weight \> 300 lbs
- braces or unremovable embedded metal
- claustrophobia or inability to lie still in MRI machine
- current or past 12-mos pregnancy (females)
- requires urgent medical/mental health care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Children's Hospitallead
- Massachusetts General Hospitalcollaborator
- Mclean Hospitalcollaborator
- Massachusetts Institute of Technologycollaborator
Study Sites (4)
McLean Hospital
Belmont, Massachusetts, 02478, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Boston University School of Medicine
Boston, Massachusetts, 02118, United States
Massachusetts Institute of Technology
Cambridge, Massachusetts, 02139, United States
Related Links
Biospecimen
Saliva DNA samples for future analyses.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John R Knight, MD
Boston Children's Hospital
- PRINCIPAL INVESTIGATOR
Gordon J Harris, PhD
Massachusetts General Hospital
- PRINCIPAL INVESTIGATOR
Simon Warfield, PhD
Boston Children's Hospital
- PRINCIPAL INVESTIGATOR
Avram Holmes, PhD
Harvard University
- PRINCIPAL INVESTIGATOR
Scott Lukas, PhD
Mclean Hospital
- PRINCIPAL INVESTIGATOR
Marisa Silveri, PhD
Mclean Hospital
- PRINCIPAL INVESTIGATOR
Marlene Oscar Berman, PhD
Boston University
- PRINCIPAL INVESTIGATOR
John Gabrieli, PhD
Massachusetts Institute of Technology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2012
First Posted
January 19, 2012
Study Start
September 1, 2012
Primary Completion
March 1, 2017
Study Completion
September 1, 2017
Last Updated
January 3, 2013
Record last verified: 2013-01